Skip to main content

Investigation of drug-adapted cancer cell lines as pre-clinical models of acquired resistance

Onafuye, Hannah (2020) Investigation of drug-adapted cancer cell lines as pre-clinical models of acquired resistance. Doctor of Philosophy (PhD) thesis, University of Kent,. (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:80795)

PDF
Language: English

Restricted to Repository staff only until March 2023.
Contact us about this Publication
[thumbnail of 187Investigation_of_drug-adapted_cancer_cell_lines_as_pre-clinical_models_of_acq.pdf]

Abstract

Drug-adapted cancer cell lines have been successfully used to identify clinically relevant drug resistance mechanisms. This project focused on the further development of drug-adapted cancer cell lines as pre-clinical models of acquired drug resistance in cancer. A new cell line panel consisting of the ovarian cancer cell lines EFO-21, EFO-27, and COLO-704 and their cisplatin-adapted sublines was introduced and characterised. In addition, doxorubicin-loaded human serum albumin (HSA) nanoparticles were shown to circumvent ABCB1-mediated drug efflux. Vincristine- but not doxorubicin-adapted cells were re-sensitised to the level of the respective parental cells by HSA nanoparticle-incorporated doxorubicin. This indicates that rational strategies to overcome drug resistance in cancer depend on an intimate understanding of (the complexity of) the underlying resistance mechanisms. Finally, a standardised treatment protocol revealed differences in the potential of the microtubule-stabilising agents; docetaxel, paclitaxel, cabazitaxel, and epothilone B to induce resistance in the neuroblastoma cell line UKF-NB-3. In conclusion, this project has contributed to resistance research in cancer by introducing novel models, by providing novel insights into the prospects and limitations of strategies to overcome resistance mediated by transporter-mediated drug efflux, and by developing a novel strategy to assess the potential of anti-cancer drugs to induce resistance.

Item Type: Thesis (Doctor of Philosophy (PhD))
Thesis advisor: Michaelis, Martin
Thesis advisor: Wass, Mark
Subjects: Q Science > QH Natural history > QH581.2 Cell Biology
Divisions: Divisions > Division of Natural Sciences > School of Biosciences
SWORD Depositor: System Moodle
Depositing User: System Moodle
Date Deposited: 09 Apr 2020 12:10 UTC
Last Modified: 20 May 2021 13:23 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/80795 (The current URI for this page, for reference purposes)
  • Depositors only (login required):